EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

A Novel De Novo MTM1 Insertion Frameshift Variant Causes X‐Linked Myotubular Myopathy in a Chinese Female

Lijun Chen iD, Yingxiao Bao, Gonglu Liu iD

Molecular Genetics & Genomic Medicine · 2026

DOI: 10.1002/mgg3.70318 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Molecular Genetics & Genomic Medicine, 2026. Verfasst von Lijun Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics and Center for Rare Diseases, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejia…. Hauptthemen laut MEDLINE: Myopathies, Structural, Congenital, Protein Tyrosine Phosphatases, Non-Receptor, Frameshift Mutation. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province, Key Research and Development Program of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

MTM1 ‐related X‐linked myotubular myopathy (XLMTM) typically affects males; however, symptomatic female carriers may occur.

Methods

We evaluated a 24‐year‐old woman with infantile hypotonia followed by slowly progressive, asymmetric proximal weakness with facial and ocular involvement. Clinical assessment, pulmonary function testing, electromyography, lower‐limb muscle MRI, and muscle biopsy were performed. Next‐generation sequencing and parental segregation analysis were conducted.

Results

The patient developed progressive functional decline leading to wheelchair dependence. Investigations showed moderate‐to‐severe restrictive ventilatory impairment, a myopathic pattern on electromyography, and extensive fatty replacement on muscle MRI. Muscle biopsy demonstrated histopathological features consistent with centronuclear myopathy. Genetic testing identified a heterozygous MTM1 insertion, c.1266_1267insATGGTGATAAAAACCATTCA, predicted to cause a frameshift (p.Gly423MetfsTer48). The variant was absent in both parents, supporting a de novo event. To our knowledge, this MTM1 variant has not been previously reported.

Conclusion

This case expands the MTM1 variant spectrum and highlights that de novo MTM1 frameshift variants can underlie clinically significant XLMTM manifestations in females, underscoring the value of genetic testing in symptomatic women with centronuclear myopathy features.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myopathies, Structural, CongenitalProtein Tyrosine Phosphatases, Non-ReceptorFrameshift MutationHumansFemaleYoung AdultPedigreeEast Asian People

Stichwörter der Autor:innen

MTM1X‐linked myotubular myopathyde novo variantrespiratory insufficiencysymptomatic female carrier

Substanzen

Protein Tyrosine Phosphatases, Non-Receptormyotubularin

Autor:innen und Institutionen

  • Department of Medical Genetics and Center for Rare Diseases, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Department of Nursing, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.

ORCID-Profile: Lijun Chen, Gonglu Liu

Förderung

  • Natural Science Foundation of Zhejiang Province
  • Key Research and Development Program of Zhejiang Province

Zitieren

APA

Chen, L., Bao, Y., & Liu, G. (2026). A Novel De Novo MTM1 Insertion Frameshift Variant Causes X‐Linked Myotubular Myopathy in a Chinese Female. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.70318

Vancouver

Chen L, Bao Y, Liu G. A Novel De Novo MTM1 Insertion Frameshift Variant Causes X‐Linked Myotubular Myopathy in a Chinese Female. Molecular Genetics & Genomic Medicine. 2026. doi:10.1002/mgg3.70318

BibTeX
@article{Chen2026,
  author = {Chen, Lijun and Bao, Yingxiao and Liu, Gonglu},
  title = {A Novel De Novo MTM1 Insertion Frameshift Variant Causes X‐Linked Myotubular Myopathy in a Chinese Female},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2026},
  doi = {10.1002/mgg3.70318}
}
Kostenlos starten →